Jordan Bakhriansyah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jordan Bakhriansyah has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Baharuddin Baharuddin
Faculty of Medicine, University of Surabaya, Kalirungkut, Surabaya, 60293, Indonesia
1 shared publication - Bambang Widyantoro
Affiliation Department of Cardiology and Vascular Medicine, Faculty of Medicine, National Cardiovascular Centre Harapan Kita, Universitas Indonesia, Jakarta, Indonesia
1 shared publication - Fathimah Andi Rumpa
Sekolah Tinggi Ilmu Kesehatan Kurnia Jaya Persada
1 shared publication - José López-Sendón
Hospital Universitario La Paz, IdiPaz Research Institute, Universidad Autonona, Madrid, Spain (J.L.-S.).
1 shared publication - Kok Han Chee
Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
1 shared publication Maita Senadrin
St Luke’s Medical Center, Quezon City, the Philippines
1 shared publication
Latest Publications
- 13 April 2026
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 81 (5) , 1-2
Interpreting platelet transfusion rate thresholds in aortic dissection: methodological considerations from a MIMIC-IV analysis
- 13 April 2026
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 81 (5) , 1-2
Interpreting platelet transfusion rate thresholds in aortic dissection: methodological considerations from a MIMIC-IV analysis
- 31 January 2026
- Published by Brawijaya University in Heart Science Journal
- Vol. 7 (1) , 124-126
Unmasking the silent threat: ST-elevation myocardial infarction in 37-year-old woman
Background: ST-elevation myocardial infarction (STEMI) has been traditionally associated with elderly males; however, its prevalence is on the rise among young women. Women often manifest with non-atherosclerotic causes of ischemic heart disease, including plaque erosion and spontaneous coronary artery dissection (SCAD); while atypical symptoms and other pathophysiological processes often result in delay in diagnosis and diagnostic or treatment differences. This case underscores the crucial role of early recognition of atypical symptoms, careful assessment of risk factors, and thoughtful selection of the best management strategies. Case Presentations: A 37-year-old woman with inadequately controlled hypertension, who did not have any traditional risk factors, presented to the emergency department with diaphoresis and epigastric pain. Initial electrocardiogram (ECG) showed inferoposterior STEMI, and coronary angiography revealed total mid RCA occlusion with nonsignificant LAD stenosis. She was immediately taken to the cath lab and primary PCI was performed with direct stenting to improve myocardial perfusion. After PCI, the patient experienced uneventful TIMI III flow restoration and was discharged on DAPT and optimal medical therapy. She was asymptomatic at the one-year follow-up, which underscores the efficacy of direct stenting in specific STEMI. Conclusions: Young women with STEMI represent a distinct and under-recognized group requiring sex specific risk stratification and tailored management to improve outcomes. Further research is needed to identify optimal therapeutic strategies for this population. Keyword : Percutaneous Coronary Intervention; Spontaneous Coronary Artery Dissection; ST-Elevation Myocardial Infarction.
- 31 January 2026
- Published by Brawijaya University in Heart Science Journal
- Vol. 7 (1) , 124-126
Unmasking the silent threat: ST-elevation myocardial infarction in 37-year-old woman
Background: ST-elevation myocardial infarction (STEMI) has been traditionally associated with elderly males; however, its prevalence is on the rise among young women. Women often manifest with non-atherosclerotic causes of ischemic heart disease, including plaque erosion and spontaneous coronary artery dissection (SCAD); while atypical symptoms and other pathophysiological processes often result in delay in diagnosis and diagnostic or treatment differences. This case underscores the crucial role of early recognition of atypical symptoms, careful assessment of risk factors, and thoughtful selection of the best management strategies. Case Presentations: A 37-year-old woman with inadequately controlled hypertension, who did not have any traditional risk factors, presented to the emergency department with diaphoresis and epigastric pain. Initial electrocardiogram (ECG) showed inferoposterior STEMI, and coronary angiography revealed total mid RCA occlusion with nonsignificant LAD stenosis. She was immediately taken to the cath lab and primary PCI was performed with direct stenting to improve myocardial perfusion. After PCI, the patient experienced uneventful TIMI III flow restoration and was discharged on DAPT and optimal medical therapy. She was asymptomatic at the one-year follow-up, which underscores the efficacy of direct stenting in specific STEMI. Conclusions: Young women with STEMI represent a distinct and under-recognized group requiring sex specific risk stratification and tailored management to improve outcomes. Further research is needed to identify optimal therapeutic strategies for this population. Keyword : Percutaneous Coronary Intervention; Spontaneous Coronary Artery Dissection; ST-Elevation Myocardial Infarction.
- Open Access
- 26 August 2025
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 4
Management of Symptomatic Patients with Chronic Coronary Syndromes: A Case-based Review on the Role of Ranolazine
Coronary artery disease is the leading cause of premature death worldwide and the resulting chronic mismatch between myocardial oxygen supply and consumption may result in angina on exertion, one of the most common symptoms of chronic coronary syndrome. As the global population increases, along with the prevalence of risk factors, especially in Asia, the burden of angina is expected to rise. Experts are advocating for the rationalisation of angina management by moving away from traditional approaches towards individualisation of therapy based on the patient’s comorbidities and underlying mechanisms of angina. Ranolazine is an antianginal drug that inhibits the late sodium ion channel currents, resulting in anti-ischaemic and antianginal effects without haemodynamic effects. This review uses a case-based approach to demonstrate the clinical utility of ranolazine in the management of patients with chronic coronary syndrome.
- 26 August 2025
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 4
Open AccessManagement of Symptomatic Patients with Chronic Coronary Syndromes: A Case-based Review on the Role of Ranolazine
Coronary artery disease is the leading cause of premature death worldwide and the resulting chronic mismatch between myocardial oxygen supply and consumption may result in angina on exertion, one of the most common symptoms of chronic coronary syndrome. As the global population increases, along with the prevalence of risk factors, especially in Asia, the burden of angina is expected to rise. Experts are advocating for the rationalisation of angina management by moving away from traditional approaches towards individualisation of therapy based on the patient’s comorbidities and underlying mechanisms of angina. Ranolazine is an antianginal drug that inhibits the late sodium ion channel currents, resulting in anti-ischaemic and antianginal effects without haemodynamic effects. This review uses a case-based approach to demonstrate the clinical utility of ranolazine in the management of patients with chronic coronary syndrome.